1.Biochemical indicators of anaphylactic shock and the application in forensic medicine.
Li MI ; Jie CHEN ; Wei-Min GAO ; Zhong-Bo DU ; Zhi-Peng CAO ; Yuan ZHANG ; Bao-Li ZHU
Journal of Forensic Medicine 2014;30(2):117-121
Fatal anaphylactic shock is common in forensic practice. However, it is difficult to diagnose for lacking specific pathological and morphologic changes in forensic autopsy. The application of some biochemical indicators is of great significance. This paper reviews the biological characteristics of some biochemical indicators and detection methods. The forensic application, problems and prospects of these indicators are also introduced in details. The stable biochemical indicators, IgE, tryptase and chymase, show great potential and advantages in the identification of fatal anaphylactic shock in forensic medicine.
Anaphylaxis/metabolism*
;
Autopsy
;
Biomarkers
;
Chymases
;
Forensic Medicine
;
Humans
;
Tryptases
2.The Influence of IgE on Cultured Human Mast Cells.
Pernille Munk FRANDSEN ; Inge Jacoba Maria Kortekaas KROHN ; Hans Jurgen HOFFMANN ; Peter Oluf SCHIOTZ
Allergy, Asthma & Immunology Research 2013;5(6):409-414
PURPOSE: The mast cell plays a pivotal role in the human immune response. Crosslinking of 2 IgE molecules bound to the high affinity IgE receptor (FcepsilonRI) on the surface of the mast cell results in mast cell degranulation and the release of several proinflammatory mediators. Patients with type-I allergy have increased levels of IgE in the blood compared to healthy individuals. METHODS: In a 6-week culture system of stem cells to human mast cells we investigated the effect of the concentration of IgE. The mast cells were cultured with different concentrations of IgE for the last 10 days of the maturation period. It was observed how the IgE concentration affects the histamine release, FcepsilonRI density on the mast cell surface and the concentration of other mediators. RESULTS: A clear correlation between IgE concentration in culture medium and the release of histamine upon activation was observed. It showed a bell-shaped dose response curve, with maximal response around an IgE-concentration of 250 ng/mL. Furthermore, the sensitivity of the mast cells and surface density of FcepsilonRI on mast cell surface was also influenced by the IgE concentration in the culture medium. CONCLUSIONS: IgE in the culture medium during the last 10 days of mast cell maturation influences the release of the preformed mediator histamine after mast cell activation and the density of FcepsilonRI on the mast cell surface. The release of the de novo synthetized mediator prostaglandin D2 and the expression of chymase and tryptase are not influenced by IgE in culture medium.
Chymases
;
Histamine
;
Histamine Release
;
Humans
;
Hygiene Hypothesis
;
Hypersensitivity
;
Immunoglobulin E
;
Mast Cells
;
Prostaglandin D2
;
Stem Cells
;
Tryptases
3.The Influence of IgE on Cultured Human Mast Cells.
Pernille Munk FRANDSEN ; Inge Jacoba Maria Kortekaas KROHN ; Hans Jurgen HOFFMANN ; Peter Oluf SCHIOTZ
Allergy, Asthma & Immunology Research 2013;5(6):409-414
PURPOSE: The mast cell plays a pivotal role in the human immune response. Crosslinking of 2 IgE molecules bound to the high affinity IgE receptor (FcepsilonRI) on the surface of the mast cell results in mast cell degranulation and the release of several proinflammatory mediators. Patients with type-I allergy have increased levels of IgE in the blood compared to healthy individuals. METHODS: In a 6-week culture system of stem cells to human mast cells we investigated the effect of the concentration of IgE. The mast cells were cultured with different concentrations of IgE for the last 10 days of the maturation period. It was observed how the IgE concentration affects the histamine release, FcepsilonRI density on the mast cell surface and the concentration of other mediators. RESULTS: A clear correlation between IgE concentration in culture medium and the release of histamine upon activation was observed. It showed a bell-shaped dose response curve, with maximal response around an IgE-concentration of 250 ng/mL. Furthermore, the sensitivity of the mast cells and surface density of FcepsilonRI on mast cell surface was also influenced by the IgE concentration in the culture medium. CONCLUSIONS: IgE in the culture medium during the last 10 days of mast cell maturation influences the release of the preformed mediator histamine after mast cell activation and the density of FcepsilonRI on the mast cell surface. The release of the de novo synthetized mediator prostaglandin D2 and the expression of chymase and tryptase are not influenced by IgE in culture medium.
Chymases
;
Histamine
;
Histamine Release
;
Humans
;
Hygiene Hypothesis
;
Hypersensitivity
;
Immunoglobulin E
;
Mast Cells
;
Prostaglandin D2
;
Stem Cells
;
Tryptases
4.Measurement of plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases.
Qiong PAN ; Mei-Fang DING ; Shu ZHANG ; Ying NING ; Hong-Wei LIU ; Hong WEI ; Hong-Ni YUE
Chinese Journal of Contemporary Pediatrics 2011;13(10):814-816
OBJECTIVETo evaluate the roles of plasma mast cell carboxypeptidase and chymase in the diagnosis of allergic diseases by measuring the contents of both in children.
METHODSA total of 59 children with allergic diseases and 53 healthy children were recruited into the study. Plasma levels of mast cell carboxypeptidase and chymase were measured using ELISA.
RESULTSThe plasma levels of mast cell carboxypeptidase and chymase in children with allergic children were 1.089 ± 0.752 ng/mL and 0.905(0.375-2.318) ng/mL, respectively, which were significantly higher than those in healthy children [0.593 ± 0.380 ng/mL and 0.454 (0.097-1.077) ng/mL respectively; P<0.05]. There was a significantly positive correlation between plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases (r=0.684, P<0.01).
CONCLUSIONSPlasma levels of mast cell carboxypeptidase and chymase increase in children with allergic diseases, suggesting that mast cell carboxypeptidase and chymase may serve as the indexes for the diagnosis of allergic diseases.
Adolescent ; Carboxypeptidases ; blood ; Child ; Child, Preschool ; Chymases ; blood ; Female ; Humans ; Hypersensitivity ; diagnosis ; enzymology ; Infant ; Infant, Newborn ; Male ; Mast Cells ; enzymology
5.Mast Cells in 10-Dimethyl-1,2 Benzanthracene (DMBA)-Induced Rat Mammary Carcinomas: Relationship with Matrix Metallproteinase (MMP)-2 and MMP-9 Expression.
Hyun Ho LEE ; Ae Ree KIM ; Bum Woo YEOM ; Insun KIM
Korean Journal of Pathology 2001;35(4):306-313
BACKGROUND: It has been suggested that mast cells are involved in the tumor growth and progression by production of a variety of enzymes and growth factors. They were studied in the 10-dimethyl-1,2 benzanthracene (DMBA)-induced rat mammary tumors, and evaluated in relation with the production of tryptase, chymase, and matrix metalloproteinase (MMP)-2 and MMP-9. METHODS: Preneoplastic and neoplastic breast tissues of Sprague-Dawley female rats were obtained every week after DMBA treatment for 12 weeks. Toluidine blue stain was used for the identification of mast cells. Mast cell tryptase was studied by immunohistochemistry, and chymase by esterase stain. MMP-2 and MMP-9 were measured by Western blotting. RESULTS: The numbers of mast cells in breast cancers were higher than in preneoplastic tissues, and there was a positive correlation between the numbers of tryptase-positive cells and the tumor size. MMP-9 quantity was correlated with the numbers of toluidine blue and chymase positive cells, but not with tryptase-positive cells and tumor size. Both active and inactive forms of MMP-2 and MMP-9 were identified in zymogram. CONCLUSIONS: The mast cells are increased in the DMBA-induced breast cancers, and their tryptase and chymase may play a role in tumor progression with or without participation of MMP-2 and MMP-9.
9,10-Dimethyl-1,2-benzanthracene
;
Animals
;
Blotting, Western
;
Breast
;
Chymases
;
Female
;
Humans
;
Immunohistochemistry
;
Intercellular Signaling Peptides and Proteins
;
Mast Cells*
;
Rats*
;
Rats, Sprague-Dawley
;
Tolonium Chloride
;
Tryptases
6.Association of CMA1 gene tag single nucleotide polymorphisms with essential hypertension in Yi population from Yunnan.
Yanrui WU ; Qian LI ; Ke YANG ; Chunjie XIAO
Chinese Journal of Medical Genetics 2014;31(4):449-454
OBJECTIVETo assess the association of tag single nucleotide polymorphisms (tag SNPs) of chymase gene (CMA1) with essential hypertension in Yi population from Yunnan, China.
METHODSA case-control study was carried out. Four tag SNPs(rs1956921, rs1800876, rs5244 and rs1885108) were genotyped in 303 patients with essential hypertension and 312 healthy controls using polymerase chain reaction - restriction fragment length polymorphism(PCR-RFLP) method.
RESULTSNo significant difference in genotypic and allelic distributions of the four polymorphisms was detected between the two groups(P>0.05), and the same results existed in the females. The frequencies of rs1956921 C allele and a C-T haplotype constructed with rs1956921 and rs5244 were greater in male patients compared with male controls(P<0.01).
CONCLUSIONThe rs1956921 C allele of the CMA1 gene and the C-T haplotype constructed with rs1956921 and rs5244 may be risk factors for essential hypertension in ethnic Yi males from Yunnan.
Adult ; Alleles ; Asian Continental Ancestry Group ; ethnology ; genetics ; Blood Pressure ; China ; ethnology ; Chymases ; genetics ; Essential Hypertension ; Female ; Humans ; Hypertension ; ethnology ; genetics ; physiopathology ; Male ; Middle Aged ; Polymorphism, Single Nucleotide
7.High-throughput screening for hamster chymase 2 inhibitors.
Shou-Bao WANG ; Xiao-Ming ZHU ; Feng GAO ; Xiao-Bin PANG ; Guan-Hua DU
Acta Pharmaceutica Sinica 2012;47(2):168-173
To screen potential hamster chymase 2 inhibitors, a high-throughput screening (HTS) model was established. Recombinant hamster chymase 2 with active form was cloned and expressed in E. coli. The HTS model with total volume of 50 microL in 384-well microplate was based on fluorescence analysis and was proved sensitive as well as specific (Z' = 0.84). A total of 40 080 samples (including 28 060 compounds and 12 020 natural products) were screened, and 613 samples with inhibition greater than 90% were selected for further rescreening. Finally, compounds J16647 and J16648 were identified with high inhibitory activity on chymase 2, and whose IC50 values were 0.823 and 0.690 micromol x L(-1), respectively.
Animals
;
Chymases
;
analysis
;
antagonists & inhibitors
;
Cricetinae
;
Enzyme Inhibitors
;
analysis
;
pharmacology
;
Escherichia coli
;
metabolism
;
High-Throughput Screening Assays
;
methods
;
Inhibitory Concentration 50
;
Rats
;
Structure-Activity Relationship
8.The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications.
Shuji SASAKI ; Toyoshi INOGUCHI
Diabetes & Metabolism Journal 2012;36(4):255-261
Oxidative stress has been paid increasing attention to as an important causative factor for diabetic vascular complications. Among possible various sources, accumulating evidence has indicated that NAD(P)H oxidase may be the most important source for reactive oxygen species production in diabetic vascular tissues. The mechanisms underlying activation and up-regulation of NAD(P)H oxidase has been supposed to be mediated by high glucose-induced protein kinase C (PKC) activation. In this review article, activation of local renin-angiotensin II system induced by chymase activation is also shown to amplify such a PKC-dependent activation of NAD(P)H oxidase. Additionally, human evidence showing the beneficial effect of antioxidants on diabetic vascular complications. Bilirubin has been recognized as a strong endogenous antioxidant. Here markedly lower prevalence of vascular complications is shown in diabetic patients with Gilbert syndrome, a congenital hyperbilirubinemia, as well as reduced markers of oxidative stress and inflammation. Lastly, statin, angiotensin II receptor blocker, chymase inhibitor, bilirubin and biliverdin, PKC beta isoform inhibitor, and glucagon-like peptide-1 analog, are shown to serve as antioxidants and have some beneficial effect on diabetic vascular complications, via inhibiting PKC-NAD(P)H oxidase activation, supporting the notion that this mechanism may be an effective therapeutic target for preventing diabetic vascular complications.
Angiotensin II
;
Antioxidants
;
Bilirubin
;
Biliverdine
;
Chymases
;
Diabetic Angiopathies
;
Gilbert Disease
;
Glucagon-Like Peptide 1
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Hyperbilirubinemia
;
Inflammation
;
NADPH Oxidase
;
Oxidative Stress
;
Oxidoreductases
;
Prevalence
;
Protein Kinase C
;
Reactive Oxygen Species
;
Receptors, Angiotensin
;
Up-Regulation
9.Role of Mast Cells in Allergic Inflammation and Innate Immunity.
Korean Journal of Pediatrics 2004;47(11):1137-1141
Mast cells play a key role in elicitation of the early-phase and late-phase IgE-mediated allergic inflammatory reactions. Mast cells are derived from pluripotent stem cells from the bone marrow. These cells migrate through circulation into connective tissues and mucosal surfaces where they mature. On the cell surfaces, mast cells have high affinity IgE receptor(FcepsilonRI), which react with specific IgE to secrete preformed and newly synthesized mediators within minutes or over a period of hours. For human mast cells, two subtypes have been recognized by the distribution of granular neutral proteases. TC-type mast cells(MCTC) contain tryptase together with chymase, cathepsin-G, and carboxypeptidase, while T-type mast cells(MCT) contain tryptase only. They also produce Th2- type cytokines to persist chronic allergic inflammation in local tissues. Mast cells have been widely studied in the context of allergic reactions and parasite infections, but there is growing evidence that they participate in innate immunity, wound healing, fibrosis, remodelling and autoimmune disease. Much research works are expected to be underwent by the development of in vitro culture system of human mast cells in addition to mast cells obtained from animals, human biopsy or cell lines. In conclusion, it is clear that mast cells are pleiotropic, multipotential and complex. More detailed research remains to be needed for further understanding of biology of mast cells and it will be helpful to develop novel treatment modality in allergic inflammation.
Animals
;
Autoimmune Diseases
;
Biology
;
Biopsy
;
Bone Marrow
;
Cell Line
;
Chymases
;
Connective Tissue
;
Cytokines
;
Fibrosis
;
Humans
;
Hypersensitivity
;
Immunity, Innate*
;
Immunoglobulin E
;
Inflammation*
;
Mast Cells*
;
Parasites
;
Peptide Hydrolases
;
Pluripotent Stem Cells
;
Tryptases
;
Wound Healing
10.Association of the Polymorphisms in the PSMA6 (rs1048990) and PSMB5 (rs2230087) Genes with Type 2 Diabetes in Korean Subjects.
Hee Kyoung KIM ; Su Won KIM ; Yun Jeong DOH ; Sae Rom KIM ; Mi Kyung KIM ; Keun Gyu PARK ; Hye Soon KIM ; Kyong Soo PARK ; Min YOO ; Jung Guk KIM ; Bo Wan KIM ; In Kyu LEE
Korean Diabetes Journal 2008;32(3):204-214
BACKGROUND: The 26S ubiquitin-proteasome system (UPS) is a principal proteolytic pathway of intracellular molecules regulating apoptosis, cell cycle, cell proliferation or differentiation, inflammation and etc. The recent study suggests that the rs1048990 (C/G) polymorphism of the proteasome subunit alpha type 6 (PSMA6) gene is associated with the increase of the risk of myocardial infarction by the dysregulation of IkappaB degradation. We hypothesized that 26S UPS is important in the development of insulin resistance and type 2 diabetes (T2DM) by controlling the degradation of IkappaB and insulin receptor substances as a substrate. We therefore investigated whether the rs1048990 (C/G) polymorphism of PSMA6 gene and the rs2230087 (G/A) polymorphism of proteasome subunit beta type 5 gene (PSMB5), that is chymotrypsin-like protease determining the rate of proteolysis, are associated with susceptibility to T2DM in Korean subjects. METHODS: We examined the polymorphisms of these genes in 309 diabetic subjects and 170 non-diabetic controls. The polymorphisms of rs1048990 (C/G) and rs2230087 (G/A) were genotyped by real-time PCR. RESULTS: The frequency of the G allele of rs1048990 (C/G) and the A allele of rs2230087 (G/A) polymorphisms was significantly higher in diabetic patients (28% and 13%) compared to that in controls (13% and 1%; P = 0.000 and P = 0.000, respectively). Logistic regression analysis of the rs1048990 (C/G) polymorphism showed that the odds ratio (OR) (adjusted for age, smoking, waist circumference, fasting plasma glucose, systolic blood pressure, HDL-C, triglyceride, and total cholesterol) was 3.93 (95% confidence interval [CI], 2.35-6.59; P = 0.000) for the G allele and 5.09 (95% CI, 2.71-9.57; P = 0.000) for CG and GG genotype when compared with the CC genotype. Logistic regression analysis of the rs2230087 (G/A) polymorphism showed that the adjusted OR was 5.70 (95% CI, 1.63-19.98; P = 0.007) for the A allele and 6.08 (95% CI, 1.66-22.29; P = 0.006) for GA and AA genotype when compared with the GG genotype. In multiple logistic regression analysis with T2DM as the independent Variable rs1048990 (C/G) and rs2230087 (G/A) polymorphisms were the predictor for T2DM. CONCLUSION: We suggest that the G allele of rs1048990 (C/G) polymorphism and the A allele of rs2230087 (G/A) polymorphism may be genetic risk factor to type 2 diabetes mellitus in Korean subjects.
Alleles
;
Apoptosis
;
Blood Pressure
;
Cell Cycle
;
Cell Proliferation
;
Chymases
;
Diabetes Mellitus, Type 2
;
Fasting
;
Genotype
;
Glucose
;
Humans
;
Inflammation
;
Insulin Resistance
;
Logistic Models
;
Myocardial Infarction
;
Odds Ratio
;
Plasma
;
Proteasome Endopeptidase Complex
;
Proteolysis
;
Receptor, Insulin
;
Risk Factors
;
Smoke
;
Smoking
;
Waist Circumference